Jeffrey J. Kraws serves as Executive at Synthetic Biologics, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey J. Kraws has executed 8 insider transactions totaling $98.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 20, 2020 involved receiving (via award) 200 shares valued at $1.1K.
Jeffrey J. Kraws currently holds 5,533 shares of Synthetic Biologics, Inc. (SYN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey J. Kraws has been a net seller of SYN stock. They have purchased $8.1K and sold $90.5K worth of shares.
Jeffrey J. Kraws's most recent insider trade was on Nov 20, 2020, when they sold 200 shares at $5.43 per share.
Get notified when new Form 4 filings are submitted
| $0.35 |
| Discretionary |
| May 22, 2020 | RMED | $4.6K | Purchase | 10,000 | $0.46 | Discretionary |
| Dec 20, 2019 | RMED | $713 | Payment | 792 | $0.90 | Discretionary |
| Dec 4, 2019 | RMED | $69.8K | Payment | 38,372 | $1.82 | Discretionary |
| Jul 18, 2019 | RMED | $35.0K | Sale | 11,930 | $2.93 | Discretionary |
| Jun 13, 2019 | RMED | $55.5K | Sale | 18,021 | $3.08 | Discretionary |
| Mar 14, 2017 | SYN | $20.6K | Option Exercise | 228,773 | $0.09 | Discretionary |